Ultraviolet B treatment for pruritus in Hodgkin's lymphoma

Kaptanoğlu, Aslı Feride; Oskay, T

doi:10.1046/j.1468-3083.2003.00614_15.x

Cited by 15 publications

(15 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A beneficial role of phototherapy has been demonstrated in atopic dermatitis (See “Management of Itch in Atopic Dermatitis” by Hong et al in this issue), 3 prurigo nodularis (UVA1, narrow band UVB and PUVA), 86 – 88 solar urticaria, 89 aquagenic pruritus, 90 CTCL, 91 Hodgkin lym-phoma, 92 polycythemia vera (narrow-band UVB), 93 HIV infection, 94 and folliculitis of pregnancy. 95 Combinations of narrow-band UVB with steroids/antihistamines or cyclo-sporin A have been successfully used for the treatment of AD or lichen amyloidosus.…”

Section: Phototherapiesmentioning

confidence: 99%

Pruritus: Management Algorithms and Experimental Therapies

Steinhoff

Cevikbas²,

Ikoma³

et al. 2011

Seminars in Cutaneous Medicine and Surgery

View full text Add to dashboard Cite

Pruritus (itch) is a major symptom in many dermatologic as well as systemic diseases and has a dramatic impact on the quality of life in these patients. The symptom of itch has to be treated on the basis of its pathophysiology and its underlying disease. In daily practice, a “quick” diagnosis of the underlying disease is often difficult, although a rapid relief of the itch is desired. We often treat patients on the basis of the symptomatology. A rational therapeutic ladder for a symptomatic therapy is useful until the final diagnosis has been confirmed. There are probably many subtypes of pruritus, just as there are many diseases that cause itch. The pathophysiology in many subtypes of pruritus is still poorly understood, hindering a rapid and targeted treatment strategy. An extensive diagnostic workup is often required to determine the final cause(s) of the itch. Thus, in daily life, physicians often start with a more or less rational therapeutic strategy to combat the debilitating itch. We present possible therapeutic ladders that form the basis for effective therapeutic itch strategies in various diseases. On the basis of our current knowledge about the different pathophysiologies of itch, on clinical trials or case reports, and our own clinical experience, we aim to present therapeutic ladders for the rapid as well as long-term management of itch. Finally, we summarize current exciting developments of experimental strategies in itch research and in clinical development for itch therapy.

show abstract

Section: Phototherapiesmentioning

confidence: 99%

Pruritus: Management Algorithms and Experimental Therapies

Steinhoff

Cevikbas²,

Ikoma³

et al. 2011

Seminars in Cutaneous Medicine and Surgery

View full text Add to dashboard Cite

show abstract

“…One woman's intractable pruritus secondary to skin infiltration of breast cancer was relieved with NB‐UVB twice weekly, with better results to an area also treated with crotamiton (76). A case of pruritus secondary to Hodgkin's lymphoma was partially treated with BB‐UVB three times a week (77). Treating the underlying disease resulted in relief for this patient as well, but the BB‐UVB was a successful palliative therapy in the interim between chemotherapy treatments (77).…”

Section: Othermentioning

confidence: 99%

“…A case of pruritus secondary to Hodgkin's lymphoma was partially treated with BB‐UVB three times a week (77). Treating the underlying disease resulted in relief for this patient as well, but the BB‐UVB was a successful palliative therapy in the interim between chemotherapy treatments (77). Five patients with acquired perforating dermatosis who complained of pruritus were treated with NB‐UVB with resolution of their lesions within 15 treatments (78).…”

Section: Othermentioning

confidence: 99%

Ultraviolet phototherapy for pruritus

Rivard

Lim

2005

Dermatol Ther

View full text Add to dashboard Cite

Ultraviolet-based therapy has been used to treat various pruritic conditions including pruritus in chronic renal failure, atopic dermatitis, HIV, aquagenic pruritus and urticaria, solar, chronic, and idiopathic urticaria, urticaria pigmentosa, polycythemia vera, pruritic folliculitis of pregnancy, breast carcinoma skin infiltration, Hodgkin's lymphoma, chronic liver disease, and acquired perforating dermatosis, among others. Various mechanisms of action for phototherapy have been posited. Treatment limitations, side effects, and common dosing protocols are reviewed.

show abstract

“…Symptomatic improvement can also be achieved by phototherapy in pruritus associated with uraemia, primary biliary cirrhosis, macular amyloidosis and Hodgkin's lymphoma (105). According to Hsu & Yang (106) uraemic pruritus responds only to bUVB but not to nUVB.…”

Section: Pruritusmentioning

confidence: 99%

Phototherapy with Narrowband vs Broadband UVB

Berneburg¹,

Röcken²,

Benedix³

2005

Acta Dermato-Venereologica

View full text Add to dashboard Cite

Phototherapy with ultraviolet (UV) radiation of wavelengths between 280 and 320 nm (UVB) is a safe and effective treatment for a variety of diseases. In addition to standard broadband UVB (bUVB), narrowband phototherapy with fluorescent bulbs emitting near monochromatic UV around 311 nm (nUVB) has become an important treatment for diseases such as psoriasis, atopic dermatitis and vitiligo. In addition to these indications, the number of diseases for which nUVB phototherapy is reported to be effective is continuously growing. The differential effects of nUVB phototherapy in comparison to other UV wavelengths as well as established and new indications for this treatment modality are reviewed.

show abstract

Ultraviolet B treatment for pruritus in Hodgkin's lymphoma

Cited by 15 publications

References 6 publications

Pruritus: Management Algorithms and Experimental Therapies

Pruritus: Management Algorithms and Experimental Therapies

Ultraviolet phototherapy for pruritus

Phototherapy with Narrowband vs Broadband UVB

Contact Info

Product

Resources

About